05.31.18
Ajinomoto Althea announced today that Bert Barbosa and Darwin Richardson, MBA, have joined Althea as vice president of Drug Product Manufacturing and vice president of Compliance, respectively.
Mr. Barbosa joins Althea after 10 years at Allergan, most recently as Director QA/QC, Drug Substance Operations. Mr. Richardson has over 25 years of quality operations and regulatory compliance leadership to Althea. Most recently, Mr. Richardson served as Senior Vice President of Quality and Regulatory Affairs at BPL Plasma.
Both Mr. Barbosa and Mr. Richardson bring extensive leadership experience in bio-pharmaceutical manufacturing and quality operations to Althea, as the company expands their contract development and manufacturing operation (CDMO) and capabilities globally in conjunction with its integration with sister company, small molecule API manufacturer Ajinomoto OmniChem.
"We are excited to welcome both Darwin and Bert to our leadership team at Althea," said J. David Enloe, Jr., president and chief executive officer of Althea. "Between them, they bring more than 60 years of commitment to manufacturing excellence, product quality and improving patients' lives. Darwin and Bert will bring tremendous value to our organization as we begin operating Ajinomoto Althea, Ajinomoto OmniChem, and ultimately the other Ajinomoto entities focused on the life science market as a single, global CDMO. This unified organization will better serve our clients by offering more complex manufacturing infrastructure to address diversifying product pipelines.”
"We are excited to welcome both Darwin and Bert to our leadership team at Althea," said J. David Enloe, Jr., president and chief executive officer of Althea. "Between them, they bring more than 60 years of commitment to manufacturing excellence, product quality and improving patients' lives. Darwin and Bert will bring tremendous value to our organization as we begin operating Ajinomoto Althea, Ajinomoto OmniChem, and ultimately the other Ajinomoto entities focused on the life science market as a single, global CDMO. This unified organization will better serve our clients by offering more complex manufacturing infrastructure to address diversifying product pipelines.”
Mr. Barbosa joins Althea after 10 years at Allergan, most recently as Director QA/QC, Drug Substance Operations. Mr. Richardson has over 25 years of quality operations and regulatory compliance leadership to Althea. Most recently, Mr. Richardson served as Senior Vice President of Quality and Regulatory Affairs at BPL Plasma.